Dry eye common in early GO

Article

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

Dr Vasilis Achtsidis et al., Attikon University Hospital, University of Athens, Greece, evaluated a total of 52 eyes of 26 patients with early GO and 37 control subjects. GO diagnosis was based on the European Group on Graves Orbitopathy consensus statement. The team also calculated Clinical Activity Score (CAS) and Werner-NOSPECS Score, as well as corneal sensitivity using a Cochet-Bonnet aesthesiometer.

Of the participants included in the study, 67.8% with early GO and 13.5% of healthy controls presented with ocular surface dryness. Mean Schirmer test scores were significantly lower in GO patients, compared to controls and these results correlated with CAS. Tear film break up time was lower in patients by 5.46 seconds and 5.74 seconds in the right and left eyes, respectively.

Dry eye is common in GO, despite the absence of apparent exophthalmos, and based on the results the team concluded that there was an association with CAS as well as reduced corneal sensitivity.

To read the abstract please visit the European Journal of Ophthalmology.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.